Proqr Therapeutics
(PRQR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -39,028 | -22,239 | -17,737 | -63,556 | -42,442 |
| Depreciation Amortization | 1,991 | 1,158 | 576 | 2,298 | 1,716 |
| Other Working Capital | -3,921 | -3,422 | -2,427 | 1,997 | 1,939 |
| Other Operating Activity | -312 | -3,569 | 3,033 | 10,014 | 3,187 |
| Operating Cash Flow | $-41,270 | $-28,071 | $-16,556 | $-49,246 | $-35,600 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -942 | -597 | -218 | -650 | -379 |
| Investing Cash Flow | $-942 | $-597 | $-218 | $-650 | $-379 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 16,508 | 709 | 320 | 3,043 | 767 |
| Common Stock Issued | 846 | 784 | 517 | 54,592 | 185 |
| Other Financing Activity | -634 | -338 | -223 | -1,412 | -958 |
| Financing Cash Flow | $16,720 | $1,155 | $615 | $56,223 | $-6 |
| Exchange Rate Effect | -1,515 | 196 | 840 | 808 | 1,748 |
| Beginning Cash Position | 130,870 | 123,268 | 123,503 | 118,250 | 117,405 |
| End Cash Position | 103,862 | 95,951 | 108,183 | 125,384 | 83,169 |
| Net Cash Flow | $-27,007 | $-27,317 | $-15,320 | $7,134 | $-34,236 |
| Free Cash Flow | |||||
| Operating Cash Flow | -41,270 | -28,071 | -16,556 | -49,246 | -35,600 |
| Capital Expenditure | -942 | -597 | -218 | -650 | -379 |
| Free Cash Flow | -42,213 | -28,668 | -16,774 | -49,896 | -35,979 |